Evaluating the influence of antibiotic resistance on the effectiveness of treatment of pediatric sepsis
DOI:
https://doi.org/10.18203/2349-3291.ijcp20253777Keywords:
Antibiotic resistance, Antimicrobial stewardship, Empirical therapy, India, Healthcare disparities, Pediatric sepsisAbstract
Background: Pediatric sepsis remains a critical contributor to morbidity and mortality globally, especially in low- and middle-income countries. The increasing burden of antimicrobial resistance (AMR) poses significant challenges to its effective treatment. This study evaluated the influence of antibiotic resistance on the management outcomes of pediatric sepsis Telangana, Indian. Aim was to assess healthcare professionals’ perspectives on the impact of antibiotic resistance on the treatment of pediatric sepsis, focusing on prescribing practices, diagnostic patterns, and clinical outcomes.
Methods: A cross-sectional questionnaire-based survey was conducted among 302 healthcare professionals in Telangana. The structured survey included five domains: demographics, awareness of AMR, antibiotic prescribing behavior, treatment outcomes, and stewardship recommendations. Data were collected through online and paper-based formats and analyzed using SPSS 26.0, employing descriptive statistics, Chi-square tests, t-tests, ANOVA, and logistic regression models.
Results: Among respondents, 91.4% encountered resistant sepsis cases, and 81.5% perceived AMR as a major treatment barrier. Only 34.7% routinely used blood cultures before initiating antibiotics. Most relied on empirical therapy (88.2%), with third-generation cephalosporins being the first line (64.6%), and 66.9% escalated to carbapenems. Prolonged hospital stays (72.8%), and increased treatment failure (58.9%) was significantly associated with resistant infections. Rural settings and lack of rapid diagnostics were major contributors to treatment inefficacy.
Conclusions: Antibiotic resistance significantly hampers pediatric sepsis management in Telangana. There is a critical need for enhanced diagnostic capacity, rational antibiotic use, and robust antimicrobial stewardship. Policy efforts must address healthcare inequities to curb the growing threat of AMR and improve pediatric outcomes.
Metrics
References
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of pediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223-30. DOI: https://doi.org/10.1016/S2213-2600(18)30063-8
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Crit Care Med. 2003;31(4):1250-6. DOI: https://doi.org/10.1097/01.CCM.0000050454.01978.3B
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8. DOI: https://doi.org/10.1097/01.PCC.0000149131.72248.E6
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200-11.
Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147-57. DOI: https://doi.org/10.1164/rccm.201412-2323OC
Weiss SL, Balamuth F, Chilutti M, Ramos MJ, McBride P, Kelly NA, et al. Identification of pediatric sepsis for epidemiologic surveillance using electronic clinical data. Pediatr Crit Care Med. 2020;21(2):113-21. DOI: https://doi.org/10.1097/PCC.0000000000002170
Schlapbach LJ, Straney L, Alexander J, MacLaren G, Festa M, Schibler A, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis. 2015;15(1):46-54. DOI: https://doi.org/10.1016/S1473-3099(14)71003-5
Gerber JS, Jackson MA, Tamma PD, Zaoutis TE, Committee on Infectious Diseases, Pediatric Infectious Diseases Society, et al. Antibiotic stewardship in pediatrics. Pediatrics. 2021;147(1):e2020040295.
Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72-80. DOI: https://doi.org/10.1016/j.mib.2019.10.008
Le Saux N, Canadian Pediatric Society, Infectious Diseases and Immunization Committee. Antimicrobial stewardship in daily practice: Managing an important resource. Pediatr Child Health, 2014;19(4):261-5. DOI: https://doi.org/10.1093/pch/19.5.261
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. CABI Digital Library. 2016:84.
Weiss SL, Peters MJ, Alhazzani W, Agus MS, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intens Care Med. 2020;46(1):10-67. DOI: https://doi.org/10.1007/s00134-019-05878-6
Alsadoon A, Alhamwah M, Alomar B, Alsubaiel S, Almutairi AF, Vishwakarma RK, et al. Association of antibiotics administration timing with mortality in children with sepsis in a tertiary care hospital of a developing country. Front Pediatr. 2020;8:566. DOI: https://doi.org/10.3389/fped.2020.00566
Robinson P, De SK. How to use Procalcitonin. Arch Dis Childhood-Educ Pract. 2018;103(5):257-62. DOI: https://doi.org/10.1136/archdischild-2017-313699
McMullan BJ, Andresen D, Blyth CC, Avent ML, Bowen AC, Britton PN, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis. 2016;16(8):e139-52. DOI: https://doi.org/10.1016/S1473-3099(16)30024-X
McWilliam S, Riordan A. How to use: c-reactive protein. Arch Dis Childhood-Educ Pract. 2010;95(2), 55-58. DOI: https://doi.org/10.1136/adc.2009.174367
Brazilian Society Immunizations. Average vaccination coverage by three years and type of vaccines in the child calendar, Brazil 1980 to 2020. 2020.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200-11.
Khalil N, Blunt HB, Li Z, Hartman T. Neonatal early onset sepsis in Middle Eastern countries: a systematic review. Arch Dis Childhood. 2020;105(7):639-47.
Khalil N, Blunt HB, Li Z, Hartman T. Neonatal early onset sepsis in Middle Eastern countries: a systematic review. Arch Dis Childhood. 2020;105(7):639-47. DOI: https://doi.org/10.1136/archdischild-2019-317110
Chaurasia S, Jeeva Sankar M, Agarwal R, Yadav CP, Arya S, Kapil A, et al. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet. 2016;4(10):e752-60. DOI: https://doi.org/10.1016/S2214-109X(16)30148-6
Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulmon Med. 2016;22(3):219-26. DOI: https://doi.org/10.1097/MCP.0000000000000263
Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, Micek ST, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62(2):130-5. DOI: https://doi.org/10.1016/j.jinf.2010.12.009
World Health Organization. Antimicrobial resistance surveillance in Europe 2023-2021 data. 2023. Available from: https://www.who.int/europe/ publications/i/item/9789289058537. Accessed on 21 June 2025.
Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014;68(4):321-31. DOI: https://doi.org/10.1016/j.jinf.2013.12.006
Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L. Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials. J Clin Oncol. 2016;34(17):2054-60. DOI: https://doi.org/10.1200/JCO.2015.65.8591
Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082-94. DOI: https://doi.org/10.1200/JCO.2016.71.7017
Castagnola E, Caviglia I, Pescetto L, Bagnasco F, Haupt R, Bandettini R. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia. Fut Microbiol. 2015;10(3):357-65. DOI: https://doi.org/10.2217/fmb.14.144
Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943-50. DOI: https://doi.org/10.1093/cid/cis588
Shankar K, Radhakrishnan V, Vijayakumar V, Ramamoorthy J, Ganesan P, Dhanushkodi M, et al. Prevalence of multi‐drug resistant organisms in stool of paediatric patients with acute leukaemia and correlation with blood culture positivity: a single institution experience. Pediatr Blood Cancer. 2018;65(1):e26740. DOI: https://doi.org/10.1002/pbc.26740
Zajac-Spychala O, Wachowiak J, Gryniewicz–Kwiatkowska O, Gietka A, Dembowska-Baginska B, Semczuk K, et al. Prevalence, epidemiology, etiology, and sensitivity of invasive bacterial infections in pediatric patients undergoing oncological treatment: a multicenter nationwide study. Microb Drug Resist. 2021;27(1):53-63. DOI: https://doi.org/10.1089/mdr.2019.0393
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. CABI Digital Library. 2016:84.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-11. DOI: https://doi.org/10.1016/S0140-6736(19)32989-7
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance- the need for global solutions. Lancet Infect Dis. 2013;13(12):1057-98. DOI: https://doi.org/10.1016/S1473-3099(13)70318-9
Dougan G, Dowson C, Overington J, Participants NG. Meeting the discovery challenge of drug-resistant infections: progress and focusing resources. Drug Discov Today. 2019;24(2):452-61. DOI: https://doi.org/10.1016/j.drudis.2018.11.015
Al-Dorzi HM, El-Saed A, Rishu AH, Balkhy HH, Memish ZA, Arabi YM. The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control. 2012;40(9):794-9. DOI: https://doi.org/10.1016/j.ajic.2011.10.004
Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. DOI: https://doi.org/10.1186/PREACCEPT-6556009101270526
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47. DOI: https://doi.org/10.1186/s13756-017-0208-x
World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit. 2019. Available at: https://www.who.int/ publications/i/item/9789241515481. Accessed on 21 June 2025.
Ranjalkar J, Chandy SJ. India’s National Action Plan for antimicrobial resistance- an overview of the context, status, and way ahead. J Fam Med Prim Care. 2019;8(6):1828-34. DOI: https://doi.org/10.4103/jfmpc.jfmpc_275_19
Downloads
Published
How to Cite
Issue
Section
